---

Novel severe acute respiratory syndrome corona virus. A review of current status and strategies in India

---

Review Article

Author Details : Abhinav Manish*, Pratibha Pandey, Nita Garg, Tariq Masood

Volume : 7, Issue : 4, Year : 2020

Article Page : 416-425

https://doi.org/10.18231/j.ijcbr.2020.089

Suggest article by email

Get Permission

---

Abstract

Corona viruses (RNA viruses) belongs to Coronaviridae family, comes under Nidoviridae family. It becomes important public health concern since the Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV) outbreak in 2002 from Guangdong Province of Southern China. Continuous evolution of corona viruses was further highlighted with the emergence of Middle-East Respiratory Syndrome(MERSCoV) outbreak in 2012 from Saudi-Arabia. Currently major concern is about the 2019 Novel CoV-2(SARSCoV-
2) that was initially identified in city of Wuhan, Hubei Province of China in December 2019. After the index case notified in China, First case of CoViD-19 was confirmed in January 2020 from India, and in March 2020 from Uttarakhand. In India there are about 800,000 active cases and about 150,000 deaths because of CoViD-19 by October 2020. Despite of that 70,00,000 cases recovered and get discharged from the CoViD centres. Uttarakhand contributed about 6000 active cases, 52000 recoveries and 1000 deaths by October 2020.Nonetheless, as the SARS-CoV and MERS-CoV were zoonotic infections but Recently,
evidence of Inter-human only transmission of SARS-CoV-2 has been accumulated and thus, the outbreak seems to be spreading among humans throughout a large parts of Uttarakhand even in the hilly areas also. Here we are providing an update on features of CoViD-19, and Providing possible solutions how to halt expansion of this pandemic and also some updates on Convalescent Plasma. 

Keywords: CoViD- 19, Convalescent Plasma, MERS-CoV, SARS-CoV.

How to cite : Manish A , Pandey P , Garg N , Masood T , Novel severe acute respiratory syndrome corona virus. A review of current status and strategies in India. Int J Clin Biochem Res 2020;7(4):416-425

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.